Research Highlights Importance of Patient-Centered Sarcoma Surveillance

A 2022 study explored how sarcoma patients feel about long-term surveillance imaging after treatment, highlighting the emotional, financial, and practical challenges that can come with ongoing follow-up care.

The study, led by Sarah C. Tepper, Anna K. Holten, Cara A. Cipriano, and colleagues evaluated patient concerns surrounding surveillance imaging through the “Sarcoma Surveillance Survey.” The research was conducted across multiple sarcoma and orthopedic oncology centers including Rush University Medical Center, Washington University in St. Louis, McMaster University and Hamilton Health Sciences, Barnes-Jewish Hospital/Siteman Cancer Center, and the University of Pennsylvania. 

After treatment for sarcoma, patients often undergo regular imaging scans for years to monitor for recurrence or spread of disease, particularly to the lungs. However, there are currently no universal guidelines for how often scans should be performed or which imaging methods are best.

To better understand the patient perspective, researchers developed a “Sarcoma Surveillance Survey” and evaluated concerns related to follow-up imaging.

The study found that many patients worried about:

• The cost of repeated scans
• Radiation exposure from CT imaging
• Anxiety while waiting for scan results or additional testing

Researchers also observed that:

• Younger patients reported greater financial concerns
• Patients traveling longer distances for care faced additional burden
• Women reported higher overall concerns related to surveillance
• Patients with higher anxiety levels were more likely to prefer more frequent imaging

Why This Matters

Surveillance scans remain an important part of sarcoma care because they help doctors monitor for recurrence and guide treatment decisions. However, this study highlights that follow-up care can also affect a patient’s emotional wellbeing and quality of life.

The findings reinforce the importance of more patient-centered surveillance strategies that consider:

• Medical needs
• Emotional health
• Financial burden
• Quality of life during survivorship

Researchers concluded that future sarcoma follow-up care may benefit from a more personalized approach, where patients and physicians work together to determine the most appropriate surveillance plan.

As rare cancer research continues to evolve, understanding the patient experience is becoming an increasingly important part of improving long-term sarcoma care.

For more detailed information, please refer to the original publication. For more information about the Synovial Sarcoma Foundation, please visit our website.